5Lei W,Mayot te J e,Levitt Ma.Enhancment of chemosensitivity and PCD by tyrosine inhibitors correlates with EGFR in NSCL[J].AnticanerRes,1999,19(1A):221.
6CHRISTOFFERSON RH , SKOLDENBERG EG,NILLSON BO. Tumor growth in a defined microcirculatlon [J]. MPMIS, 1997, 105(6): 487.
7MAEDA H, KAMEYAMA Y, NAKANE S, et al. Epithelial dysplasiaproduced by carcinogen pretreatment and subsequent wounding[J]. Oral Surg Oral Med Oral Pathol, 1989, 68: 50.
8BOSCH F X, MANOS M M. MUIqOZ N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study oncervical cancer (IBSCC) Study Group[J]. J Nail Cancer Inst, 1995, 87(11): 796-802.
9CHRISTOFFERSON R H, SKOLDENBERG E G, NILS- SON B O. Tumor growth in a defined microcirculation[J]. APMIS, 1997, 105(6): 487-496.
10KAUFMANN Y, LUO S, JOHNSON A, et al. Timing of oral glutamine on DMBA-induced tumorigenesis[J]. J Surg Res, 2003, 111(1): 158-165.
